Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 NOK | 0.00% | -17.11% | -94.36% |
Apr. 17 | Ultimovacs to Reduce 40% of Workforce Amid Operational Adjustments | MT |
Apr. 17 | Transcript : Ultimovacs ASA - Special Call |
Sales 2024 * | 954M 87.03M | Sales 2025 * | - | Capitalization | 238M 21.76M |
---|---|---|---|---|---|
Net income 2024 * | 654M 59.69M | Net income 2025 * | -140M -12.78M | EV / Sales 2024 * | -0.98 x |
Net cash position 2024 * | 1.18B 107M | Net cash position 2025 * | 1.05B 95.79M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
0.42
x | P/E ratio 2025 * |
-1.81
x | Employees | 26 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.97% |
Latest transcript on Ultimovacs ASA
1 week | -17.11% | ||
Current month | -13.05% | ||
1 month | -12.28% | ||
3 months | -94.97% | ||
6 months | -93.08% | ||
Current year | -94.36% |
Managers | Title | Age | Since |
---|---|---|---|
Carlos de Sousa
CEO | Chief Executive Officer | 66 | 20-05-31 |
Director of Finance/CFO | 57 | - | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jónas Einarsson
CHM | Chairman | 67 | 11-01-25 |
Henrik Schüssler
BRD | Director/Board Member | 61 | 14-12-31 |
Kari Grønås
BRD | Director/Board Member | 59 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 6.93 | -8.58% | 840,001 |
24-04-24 | 7.58 | -3.56% | 496,380 |
24-04-23 | 7.86 | -0.51% | 287,821 |
24-04-22 | 7.9 | -4.93% | 261,462 |
24-04-19 | 8.31 | -0.60% | 574,668 |
Real-time Oslo Bors, April 25, 2024 at 10:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-94.36% | 21.7M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ULTI Stock